Prognosis-predicting system based on factors related to survival of cervical carcinoma

International Journal of Gynecology and Obstetrics

Volumn 63, Issue 2, 1998, Pages 163-167

  Yuan, Chiou Chung ^a   Wang, Peng Hui ^a   Lai, Chiung Ru ^a   Yen, Ming Shyen ^a   Chen, Chih Yu ^a   Juang, Chi Mon ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cervical carcinoma; Prognosis predicting system

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL TIME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY;

EID: 0032443550     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(98)00142-8     Document Type: Article

References (26)

1. Sevin BU, Nadji M, Lampe Bet al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer. 76:1995;1978-1986.
2. Sevin BU, Lu Y, Bloch DAet al. Surgically defined prognostic parameters in patients with early cervical carcinoma. Cancer. 78:1996;1938-1946.
3. Gynning I, Johnsson JE, Aim P, Trope C Age and prognosis in stage lb squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 15:1983;18-26.
4. Kjorstad KE Carcinoma of the cervix in the young patients. Obstet Gynecol. 50:1977;28-30.
5. Stanhope CR, Smith TP, Wharton JT, Rutledge FN, Fletcher GH, Gallager HS Carcinoma of cervix: the effect of age on survival. Gynecol Oncol. 10:1980;188-193.
6. Alvarez RD, Soong SJ, Kinney WKet al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol. 35:1989;130-135.
7. Lai CH, Chang HC, Chang TC, Hsueh S, Tang SG Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. Gynecol Oncol. 51:1993;390-396.
8. Smiley LM, Burke TW, Silva EG, Morris M, Gershenson DM, Wharton JT Prognostic factors in stage Ib squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol. 77:1991;271-275.
9. Lee YN, Wang KL, Lin MHet al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases. Gynecol Oncol. 32:1989;135-142.
10. Sigurdsson K, Harfnkelsson J, Geirsson G, Gudumundsson J, Salvarsdottir A Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factor based on Icelandic population data, 1964-1988. Gynecol Oncol. 43:1991;64-70.
11. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT Adjuvant radiotherapy following radical hysterectomy for patients with stage Ib and IIa cervical cancer. Gynecol Oncol. 37:1990;390-395.
12. Tattersall MHN, Ramirez C, Coppleson M A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol. 46:1992;176-181.
13. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F Prospective surgical-pathological study of disease-free interval in patients with stage Ib squamous cell carcinoma of the cervix. Gynecol Oncol. 38:1990;352-357.
14. Kumura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa MSet al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186.
15. Kurman RJ, Norris HJ, Wilkinson EJ. Atlas of tumor pathology. Tumors of the cervix, vagina, and vulva. Washington DC: Armed Forces Institute of Pathology, 1992.
16. Reagan JW, Hamonic MJ, Wentz WB Analytical study of the cells in cervical squamous cell cancer. Lab Invest. 6:1957;241-247.
17. Wang PH, Liu RC, Lai CRet al. Small cell carcinoma of the cervix: analysis of clinical and pathological findings. Eur J Gynecol Oncol. 19:1998;189-192.
18. SAS/STAT User's Guide, release 6.03 edition. Cary (NC): SAS Institute, 1988.
19. Kaplan EL, Meier P Non-parametric estimation from incomplete observation. J Am Stat Assoc. 4:1986;57-81.
20. Mantel N Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
21. Cox DR Regression models and life tables. J R Stat Soc B. 34:1972;187-220.
22. Zreik TG, Chambers JT, Chambers SK Parametrial involvement, ragardless of nodal status: a poor prognostic factor for cervical cancer. Obstet Gynecol. 87:1996;741-746.
23. Yuan CC, Wang PH, Lai CR, Tsu EJ, Yen MS, Ng HT. Recurrence and survival analyses of 1115 cervical cancer patients treated with radical hysterectomy. Gynecol Obstet Invest, in press.
24. Burghardt E, Pickel H, Haas J, Lahousen M Prognostic factors and operative treatment of stage Ib to IIb cervical cancer. Am J Obstet Gynecol. 156:1987;988-996.
25. Chou CY, Hsu KF, Wang ST, Huang SC, Tzeng CC, Huang KE Accuracy of three-dimensional ultrasonography in volume estimation of cervical carcinoma. Gynecol Oncol. 66:1997;89-93.
26. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F A prospective surgical pathological study of stage I squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 35:1989;314-320.